The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

CRH  -  corticotropin releasing hormone

Canis lupus familiaris

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of CRH

  • After CRH administration, the increment in plasma ACTH was significantly (p < 0.05) lower in dogs with pituitary-dependent hyperadrenocorticism (221 +/- 53 ng/l) than that in control dogs (279 +/- 41 ng/l) [1].
  • In conclusion, canine corticotrophic adenomas are less sensitive to stimulation by CRH and less sensitive to inhibition by glucocorticoids [2].
  • Therefore, stimulation with CRH produced 2 patterns of plasma IR-ACTH response when administered to dogs with naturally acquired adrenal insufficiency [3].
  • Of the 7 dogs with primary adrenal insufficiency, 6 had markedly high basal plasma IR-ACTH concentrations and exaggerated ACTH responses to CRH administration, whereas 1 dog that was receiving replacement doses of prednisone at the time of testing had normal basal IR-ACTH concentrations and a nearly normal response to CRH [3].
  • Responsiveness to corticotropin-releasing hormone and vasopressin in canine Cushing's syndrome [1].
 

High impact information on CRH

  • In the old dogs, the stress- and CRH-induced cortisol peaks were relatively higher than those of ACTH, and their adrenals weighed significantly more, suggesting chronic hyperadrenocorticotropism [4].
  • After stress by immobilization as well as by light electric foot shocks and after i.v. administration of 1 microgram/kg CRH, the old dogs had higher peak levels of ACTH and cortisol, but not of alpha MSH [4].
  • The CRH-induced ACTH secretion by corticotrophic adenoma cells was significantly (P < 0.05) lower than that by normal pituitary cells after 4 h incubation with CRH [2].
  • CRH, AVP, IGF-I and cortisol had no effect on the proliferation of canine pituitary cells or canine corticotrophic adenoma cells [2].
  • For the purpose of obtaining an integral picture of anterior pituitary function in canine pituitary-dependent hyperadrenocorticism (PDH), 47 dogs with PDH and eight control dogs received combined administration of four hypophysiotropic hormones (CRH, GHRH, GnRH and TRH) and measurements were made of ACTH, cortisol, GH, LH, PRL and TSH [5].
 

Chemical compound and disease context of CRH

  • The ACTH secretion by corticotropic cells in pituitary-dependent hyperadrenocorticism was relatively less sensitive to stimulation with CRH than with LVP [1].
 

Biological context of CRH

  • The AUC of the plasma cortisol vs. time curve following CRH stimulation, a measure of adrenal suppression, was reduced significantly after topical application of BMV compared with the pretreatment values [6].
 

Anatomical context of CRH

  • Preliminary data confirmed the existence of the highest cross-reactivity of a canine hypothalamus extract, known to have a high content of CRH, with antisera directed against human, rat CRH [7].
  • The CRH gene was amplified from genomic DNA obtained from white blood cells by a polymerase chain reaction and subsequently sequenced using the dideoxy method [7].
  • Upon presentation of a dog, CRH increased in the amygdala of the sheep and then fell off [8].
  • Repeated stress also produced an exaggeration in both of the CRH peaks to presentation of a subsequent novel stress (a forelimb electric shock) [8].
  • After CRH stimulation testing and MRI, dogs were euthanatized and the pituitary gland and adrenal glands were excised for gross and histologic examination [9].
 

Associations of CRH with chemical compounds

  • In contrast, DEX + DOM-treated dogs had daily mean ACTH concentrations ranging from 10 +/- 8.1 to 32 +/- 26 pg/ml and mean peak post-CRH ACTH concentrations of 174 +/- 16 pg/ml [10].
  • Corticotropin-releasing hormone (CRH) and vasopressin are the most important hypothalamic factors regulating adrenocorticotropic hormone (ACTH) secretion [1].
  • These results support a role for CRH in the physiologic regulation of ACTH secretion from the canine anterior pituitary, but do not support regulatory roles for AVP, OT, or AII [11].
  • Two weeks after termination of daily prednisone administration, significant difference between group means was not evident in baseline ACTH or cortisol values, post-CRH ACTH or cortisol values, or post-ACTH cortisol values, compared with values in controls [12].
  • Compared with separate administration, the combined administration of these four hypothalamic releasing hormones caused no apparent inhibition or synergism with respect to the responses to CRH, GHRH, and TRH [13].
 

Analytical, diagnostic and therapeutic context of CRH

References

  1. Responsiveness to corticotropin-releasing hormone and vasopressin in canine Cushing's syndrome. van Wijk, P.A., Rijnberk, A., Croughs, R.J., Wolfswinkel, J., Selman, P.J., Mol, J.A. Eur. J. Endocrinol. (1994) [Pubmed]
  2. Effects of corticotrophin-releasing hormone, vasopressin and insulin-like growth factor-I on proliferation of and adrenocorticotrophic hormone secretion by canine corticotrophic adenoma cells in vitro. van Wijk, P.A., Rijnberk, A., Croughs, R.J., Meij, B.P., Mol, J.A. Eur. J. Endocrinol. (1998) [Pubmed]
  3. Effects of synthetic ovine corticotropin-releasing hormone on plasma concentrations of immunoreactive adrenocorticotropin, alpha-melanocyte-stimulating hormone, and cortisol in dogs with naturally acquired adrenocortical insufficiency. Peterson, M.E., Kemppainen, R.J., Orth, D.N. Am. J. Vet. Res. (1992) [Pubmed]
  4. Increased neuroendocrine reactivity and decreased brain mineralocorticoid receptor-binding capacity in aged dogs. Rothuizen, J., Reul, J.M., van Sluijs, F.J., Mol, J.A., Rijnberk, A., de Kloet, E.R. Endocrinology (1993) [Pubmed]
  5. Alterations in anterior pituitary function of dogs with pituitary-dependent hyperadrenocorticism. Meij, B.P., Mol, J.A., Bevers, M.M., Rijnberk, A. J. Endocrinol. (1997) [Pubmed]
  6. Aspects of pharmacodynamics and biotransformation of the glucocorticoid resocortol butyrate. Coert, A., Verheijen, F., Horspool, L.J., Mol, J.A. J. Vet. Pharmacol. Ther. (2004) [Pubmed]
  7. Predicted primary and antigenic structure of canine corticotropin releasing hormone. Mol, J.A., van Wolferen, M., Kwant, M., Meloen, R. Neuropeptides (1994) [Pubmed]
  8. Glucocorticoid feedback increases the sensitivity of the limbic system to stress. Cook, C.J. Physiol. Behav. (2002) [Pubmed]
  9. Effect of mitotane on pituitary corticotrophs in clinically normal dogs. Taoda, T., Hara, Y., Takekoshi, S., Itoh, J., Teramoto, A., Osamura, R.Y., Tagawa, M. Am. J. Vet. Res. (2006) [Pubmed]
  10. Domperidone treatment enhances corticotropin-releasing hormone stimulated adrenocorticotropic hormone release from the dog pituitary. Zerbe, C.A., Clark, T.P., Sartin, J.L., Kemppainen, R.J. Neuroendocrinology (1993) [Pubmed]
  11. Regulation of adrenocorticotropin secretion from cultured canine anterior pituitary cells. Kemppainen, R.J., Clark, T.P., Sartin, J.L., Zerbe, C.A. Am. J. Vet. Res. (1992) [Pubmed]
  12. Duration of pituitary and adrenocortical suppression after long-term administration of anti-inflammatory doses of prednisone in dogs. Moore, G.E., Hoenig, M. Am. J. Vet. Res. (1992) [Pubmed]
  13. Assessment of a combined anterior pituitary function test in beagle dogs: rapid sequential intravenous administration of four hypothalamic releasing hormones. Meij, B.P., Mol, J.A., Hazewinkel, H.A., Bevers, M.M., Rijnberk, A. Domest. Anim. Endocrinol. (1996) [Pubmed]
  14. Validation of a chemiluminescent enzyme immunometric assay for plasma adrenocorticotropic hormone in the dog. Scott-Moncrieff, J.C., Koshko, M.A., Brown, J.A., Hill, K., Refsal, K.R. Veterinary clinical pathology / American Society for Veterinary Clinical Pathology. (2003) [Pubmed]
 
WikiGenes - Universities